Scientific Advisory Board Strengthens Atavistik Bio’s Mission of Harnessing the Power of Protein-Metabolite Interactions to add a New Lens to Drug Discovery CAMBRIDGE, Mass.–(BUSINESS WIRE)–Atavistik Bio, a pre-clinical biotechnology company that is leveraging their scalable and systematic platform to identify novel regulatory sites on proteins to restore function in disease, announced the formation of its … [Read more…]
Industry-leading talent joins leadership team as company accelerates its CLAROMER™ drug platform Tony Verco, MD, MBA, appointed Chief Medical Officer Beth Burnside, PhD, appointed Senior Vice President of Research and Development Strategy Donald Treacy, Jr., PhD, appointed Senior Vice President, Development Operations AUSTIN, Texas–(BUSINESS WIRE)–Maxwell Biosciences (“Maxwell”), a preclinical drug platform company focused on the … [Read more…]
SOUTH SAN FRANCISCO, Calif. & SYDNEY–(BUSINESS WIRE)–Twist Bioscience (Nasdaq: TWST) and the Australian Research Council (ARC) Centre of Excellence in Synthetic Biology (CoESB) today announced a partnership that will enable CoESB members and partners to order a wide range of Twist products that facilitate research and development. Australia’s commitment to the growing market of synthetic … [Read more…]
Fund starting with $3.5 million of commitments; targeting $20 million Venture Philanthropy model to transform the therapeutic development landscape for disease category impacting more than 20 million people NEW YORK–(BUSINESS WIRE)–National Hemophilia Foundation (NHF), the leading global organization funding inheritable blood disorders research, education, and community advocacy, today announced the launch of Pathway to Cures … [Read more…]
Building off initial investment, global investment firm adds Microsearch Laboratories to increase testing capacity; ifp-labs also announces new executive team to bring group forward BERLIN–(BUSINESS WIRE)–#industrialtech–ifp-labs, a laboratory group providing analytical testing services for food, feed, water and pharmaceuticals created by global, technology-focused investment firm Battery Ventures, today announced its launch. With its headquarters in … [Read more…]
Clinically validated and easy to use, Index BPM is an all-in-one solution to view blood pressure readings alongside other Garmin health and fitness data in the Garmin Connect app OLATHE, Kan.–(BUSINESS WIRE)–Garmin International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the Index™ BPM, its first smart blood pressure monitor that lets users … [Read more…]
− NorthStar is further expanding commercial-scale domestic radioisotope production capabilities using IBA’s environmentally preferable Rhodotron® accelerator technology – BELOIT, Wis. & LOUVAIN-LA-NEUVE, Belgium–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC (‘NorthStar’), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and IBA (Ion Beam Applications S.A., EURONEXT), the world … [Read more…]
– AMVUTTRA Demonstrated Halting or Reversal in Neuropathy Impairment with Subcutaneous Administration Once Every Three Months – – Decision Follows Positive Opinion from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) in July 2022 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that … [Read more…]
The Sensitive Skincare Faculty is a first-of-its-kind global community of experts dedicated to creating a better life for people with sensitive skin The Sensitive Skincare Faculty will focus on three core pillars of activities: research, innovation and engagement Two grants have been awarded to the George Washington University School of Medicine and Health Sciences to … [Read more…]
Start-up agreement is major step forward in readiness to conduct Phase 1b clinical trial of Company’s HOCl-based respiratory infection drug candidate, SPX-001 Partner and SpectrumX will align on detailed clinical trial protocol to discuss with the MHRA at Scientific Advisory Meeting, currently scheduled for 14 November 2022 LONDON–(BUSINESS WIRE)–SpectrumX, a UK-based healthcare and pharmaceutical company, … [Read more…]
